The 8-hour Buprenorphine Training - PART 1 - 3/11/2023-The Half and Half Course Agenda

The Half and Half Course Agenda

Pdf Summary

The PCSS Half and Half Course is a training program that focuses on office-based treatment for opioid use disorders. It is divided into two parts, with Part 1 covering various topics related to the treatment. The course is designed to provide a comprehensive understanding of the treatment process using buprenorphine/naloxone. <br /><br />The training begins with an overview of opioid use disorder treatment with buprenorphine/naloxone, followed by a section on patient evaluation. Specialty topics related to the treatment are also discussed. The course includes case studies to illustrate real-life scenarios and help participants apply the knowledge they have learned.<br /><br />Clinical uses of buprenorphine are covered in a separate section, which is followed by another case study. The importance of urine drug testing in the treatment process is also highlighted. <br /><br />Additionally, an overview of clinical tools is provided, giving participants an understanding of the resources available to support their practice. The course concludes with a Q&A session to address any questions or concerns participants may have.<br /><br />Throughout the training, there will be interactive polling questions that randomly appear. Participants are required to answer these questions, which are not graded but contribute to their participation credit. These questions help the organizers assess understanding of the material and ensure that participants are actively engaged in the training.<br /><br />The initiative is funded by SAMHSA through grant no. 1H79TI081968. It is important to note that the views expressed in the training materials and by speakers do not necessarily reflect the official policies of the Department of Health and Human Services, and any mention of trade names, commercial practices, or organizations does not imply endorsement by the U.S. Government.

Keywords

PCSS Half and Half Course

office-based treatment

opioid use disorders

buprenorphine/naloxone

patient evaluation

specialty topics

case studies

urine drug testing

clinical tools

Q&A session